Phase 2 Refractory Diffuse Large B-cell Lymphoma (DLBCL) Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden

LymphomaRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Liling Zhang40 enrolled1 locationNCT06867536

Recruiting

Phase 2

DALY II USA/ MB-CART2019.1 for DLBCL

Central Nervous System LymphomaTransformed LymphomaMantle Cell Lymphoma (MCL)+5 more

Miltenyi Biomedicine GmbH248 enrolled25 locationsNCT04792489